Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 11:12:1595147.
doi: 10.3389/fvets.2025.1595147. eCollection 2025.

Evaluation of clopidogrel responsiveness using the Platelet Function Analyzer-200 (PFA-200) in dogs

Affiliations

Evaluation of clopidogrel responsiveness using the Platelet Function Analyzer-200 (PFA-200) in dogs

Joon-Ho Shin et al. Front Vet Sci. .

Abstract

We aimed to evaluate the prevalence of clopidogrel resistance in hypercoagulable dogs using the Platelet Function Analyzer-200 (PFA-200) P2Y cartridge; further, we aimed to assess the utility of hematocrit (HCT), platelet count (PLT), prothrombin time (PT), activated partial thromboplastin time (aPTT), thromboelastography (TEG) parameters, and D-dimer level as indicators of clopidogrel efficacy. Forty healthy dogs underwent single measurements of P2Y closure time (CT), HCT, PLT, PT, aPTT, TEG parameters, and D-dimer levels, while thirty hypercoagulable dogs underwent two measurements of these parameters before and after clopidogrel treatment. The reference interval for P2Y CT in healthy dogs was 40.0-141.5 s, with a mean of 63.9 ± 26.82 s. Hypercoagulable dogs showed a mean baseline P2Y CT of 77.4 ± 37.6 s. Moreover, 23 (76.67%) and 7 (23.33%) showed responsiveness and resistance to the initial clopidogrel dose, respectively. The mean P2Y CT of the clopidogrel-resistant group after clopidogrel administration was 182.71 ± 78.43 s. Increasing the maintenance dose successfully overcame clopidogrel resistance in these seven dogs. Among the assessed parameters, only D-dimer levels showed a significant decrease in the clopidogrel-responder group (p < 0.05), suggesting its potential utility in evaluating responsiveness. In conclusion, the PFA-200 P2Y cartridge effectively detects clopidogrel resistance in dogs and can guide therapeutic adjustments such as dose escalation.

Keywords: P2Y cartridge; PFA; Platelet Function Analyzer; clopidogrel resistance; dogs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The Platelet Function Analyzer −200 device used to assess the antiplatelet effects of clopidogrel. Citrate-treated blood is dispensed into the P2Y cartridge.
Figure 2
Figure 2
Box-and-Whisker plots of P2Y closure time (CT) in the healthy and hypercoagulable groups. The boxes indicate the interquartile ranges (25th–75th percentile) and lines within the boxes indicate the median values. Whiskers indicate either 1.5 times the interquartile range or the range limit for the data, whichever is less. Circles represent mild outliers, which are values exceeding 1.5 times the interquartile range below the 25th percentile or above the 75th percentile. Asterisks represent extreme outliers, which are values exceeding three times the interquartile range beyond these percentiles. The hypercoagulable group shows prolonged P2Y CT compared to the healthy group (p < 0.05, Mann–Whitney U test).
Figure 3
Figure 3
Pie chart of proportion of dogs by responsive dosage. Among the 30 dogs in the hypercoagulable group, 76.67, 16.67, 3.33, 3.33% of the dogs showed clopidogrel responsiveness at 2 mg/kg, 4 mg/kg, 6 mg/kg, and 8 mg/kg once daily, respectively.

Similar articles

References

    1. Al-Abcha A, Radwan Y, Blais D, Mazzaferri EL, Boudoulas KD, Essa EM, et al. Genotype-guided use of P2Y12 inhibitors: a review of current state of the art. Front Cardiovasc Med. (2022) 9:850028. doi: 10.3389/fcvm.2022.850028 - DOI - PMC - PubMed
    1. Kim Y, Weissler EH, Pack N, Latz CA. A systematic review of clopidogrel resistance in vascular surgery: current perspectives and future directions. Ann Vasc Surg. (2023) 91:257–65. doi: 10.1016/j.avsg.2022.12.071, PMID: - DOI - PubMed
    1. Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol. (2005) 45:1157–64. doi: 10.1016/j.jacc.2005.01.034, PMID: - DOI - PubMed
    1. Griebsch C, Hall E, Barrs VR. Effectiveness of aspirin vs. clopidogrel in dogs with immune mediated haemolytic anaemia evaluated by serial thromboelastography and platelet mapping. Vet J. (2022) 287:105882. doi: 10.1016/j.tvjl.2022.105882, PMID: - DOI - PubMed
    1. Rosati T, Jandrey KE, Stern JA, Nguyen N, Li RHL. Evaluation of clopidogrel response in healthy cats using a novel viscoelastic test and thromboelastography. Front Vet Sci. (2024) 11:1371781. doi: 10.3389/fvets.2024.1371781, PMID: - DOI - PMC - PubMed

LinkOut - more resources